Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This trial will be conducted to study the efficacy and safety of Silodosin in the treatment of female lower urinary tract symptoms.
Full description
The double blinded randomized controlled trial will evaluate efficacy and safety of silodosin in treatment of female lower urinary tract symptoms by comparing with placebo.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
278 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Tariq F AL-Shaiji, MD; Majd Alkabbani, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal